Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: jim...

jim...

posted on Nov 07, 2006 11:19AM
think we all enjoyed our dividends at that time. We didn't know the real cash situation.IMO, the first one was ok, second one wasn't necessary. I am not sure about mismanagement, bcause Mr. Pohl has done a lot more for the share price than all others before him. However, I just want to claim on him to be more cautious with his statement like - Dutton report comes out at the end of Octobre - SEC-filings will be out at xxxx - ........ Well, we have the chance to see if he is able to change some things. Otherwise the next SMH could be very intresting. GTLA S402005
Share
New Message
Please login to post a reply